Health News
Today July 17
-
July 13, 2018 16:20 KST
- ResMed, Verily to Form Joint Venture to Help Reach Millions of Untreated Sleep Apnea Sufferers
- ResMed (NYSE: RMD, ASX: RMD), a global leader in sleep apnea treatment and connected health solutions, and Ver...
-
July 13, 2018 13:25 KST
- Dr. Yu-mi Jung of Magic Kiss Dental Clinic, Patented for orthodontic technique to improve gummy smile
- Dr. Yu-mi Jung of Magic Kiss Dental Clinic acquired a patent for the technique to improve gummy smile and corr...
-
July 12, 2018 18:00 KST
- Phase 3 Trial of NINLARO® (ixazomib) as Maintenance Therapy Met Primary Endpoint Demonstrating Statistically Significant Improvement in Progression-Free Survival in Patients with Multiple Myeloma Post-Transplant
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the randomized, Phase 3 TOURMALINE-MM3 ...
-
July 12, 2018 16:15 KST
- EUSA Pharma: NICE Approves the Targeted Cancer Immunotherapy, QARZIBA®▼ (dinutuximab beta) to Treat Children with High-Risk Neuroblastoma
- EUSA Pharma today welcomed a decision by the National Institute for Health and Care Excellence (NICE) to recom...
-
July 11, 2018 17:20 KST
- President Clinton to Deliver Closing Keynote Address on Eliminating Preventable Deaths in Hospitals at the 7th Annual World Patient Safety, Science & Technology Summit
- For the seventh year in a row, U.S. President Bill Clinton will address healthcare leaders and deliver the clo...
-
July 11, 2018 10:50 KST
- Takeda Receives Clearance from the United States Federal Trade Commission for the Proposed Acquisition of Shire plc
- Takeda Pharmaceutical Company Limited:
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, D...
-
July 10, 2018 17:35 KST
- Boehringer Ingelheim Invests More Than €200 Million to Establish Strategic Production Center for Veterinary Public Health in France
- Boehringer Ingelheim today announced an investment of more than €200 million into a new strategic production c...
-
July 10, 2018 11:05 KST
- Celgene and Acceleron Announce Luspatercept Achieved Primary and All Key Secondary Endpoints in Phase III ‘BELIEVE’ Study in Adults with Transfusion-Dependent Beta-Thalassemia
- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a pha...
-
July 06, 2018 14:00 KST
- Morinaga Milk Obtains Self-Affirmed GRAS Status for Its Proprietary Immunogenic Ingredient LAC-Shield™
- Morinaga Milk Industry Co., Ltd., (TOKYO:2264) today announced it has attained self-affirmed GRAS (generally r...
-
July 03, 2018 18:50 KST
- New Analysis of Rekovelle® Data Further Supports Use of AMH to Personalise Fertility Treatment
- Ferring Pharmaceuticals announced today a new analysis* of data from the Phase 3 ESTHER-1 trial[1] showing tha...
-
July 03, 2018 17:05 KST
- Takeda Global Headquarters Grand Opening
- Takeda Pharmaceutical Company Limited, (“Takeda”) (TOKYO:4502) today held the grand opening of Takeda Global H...
-
July 02, 2018 17:55 KST
- CHMP issues positive opinion to expand Jardiance®, Synjardy® and Glyxambi® labels to include positive effects on cardiovascular and renal outcomes
- Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) announced today that the European Medicines Agency (...
-
July 02, 2018 17:25 KST
- New Study Investigates the Utility of Masimo ORi™ (Oxygen Reserve Index) in Providing Early Detection of Blood Oxygenation Decrease During One-Lung Ventilation
- Masimo (NASDAQ: MASI) announced today the findings of a study in which researchers evaluated the ability of Ma...
-
July 02, 2018 10:00 KST
- Alteogen and Lynkogen Enter into an Exclusive Option Agreement to Develop Proprietary Fusion Proteins for the Treatment of NASH and Metabolic Diseases
- Alteogen Inc. (KOSDAQ:196170) and Lynkogen Inc. today announced that they have entered into an exclusive optio...
-
June 29, 2018 17:30 KST
- World Scleroderma Day 2018: Families open up about supporting a loved one with scleroderma, in new video series
- Boehringer Ingelheim today reveals a new collection of unique, personal stories and portraits from family memb...
-
June 27, 2018 17:25 KST
- New patient survey reveals: For people with atrial fibrillation, reversal of their blood thinning treatment is highly important
- Results from a survey in five countries among 902 people living with atrial fibrillation (AF) reinforce the im...
-
June 27, 2018 16:00 KST
- United Arab Emirates Ministry of Health & Prevention Adopts National CCHD Newborn Screening Program Using Masimo Rad-97™ Pulse CO-Oximeters® with Eve™
- Masimo (NASDAQ: MASI) announced today that the United Arab Emirates (UAE) Ministry of Health & Prevention (MOH...
-
June 27, 2018 14:00 KST
- 22nd Century Announces New Non-GMO, Very Low Nicotine Flue-Cured and Burley Tobacco Varieties
- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in tobacco harm...
-
June 26, 2018 09:25 KST
- Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes
- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that both randomised controlled tri...
-
June 25, 2018 10:00 KST
- Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
- Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (...
-
June 19, 2018 13:45 KST
- Octapharma announces approval of new Nuwiq® product strengths in Europe, increasing dosing flexibility for patients with haemophilia A
- Octapharma announced today that the European Medicines Agency (EMA) has approved an extension of marketing aut...
-
June 15, 2018 13:25 KST
- Brightree Announces eReferral Integration with athenahealth
- Brightree, the leading provider of cloud-based software helping post-acute care companies improve business per...
-
June 12, 2018 14:45 KST
- New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which r...
-
June 11, 2018 10:25 KST
- Takeda Announces Term Loan Credit Agreement and Amendment to Bridge Credit Agreement in Connection with Proposed Shire Acquisition
- Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) announces that it has today entered into a term l...
-
June 08, 2018 10:55 KST
- Impossible Foods Checks in to Hong Kong Hotels
- Impossible Foods is offering its award-winning, plant-based meat at three of Hong Kong’s top-ranking hotels: H...
-
June 07, 2018 15:15 KST
- Sonion and Valencell Partner to Make Biometrics Universal in Hearables and Hearing Health Markets
- Sonion, the global leader in micro acoustic and micro mechanical technologies and solutions for hearing instru...
-
June 06, 2018 12:40 KST
- Nerviano Medical Sciences Announces Collaboration and License Agreement with Merck to Discover Small Molecule Inhibitors of Certain Anticancer Targets
- Today Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy and one of the leading oncol...
-
June 05, 2018 14:00 KST
- New ResMed-sponsored Study Shows Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination
- A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP)...
-
June 05, 2018 11:50 KST
- New Study Investigates the Utility of Continuous Noninvasive Hemoglobin Measurement With Masimo SpHb® for Reflecting Real-time Iatrogenic Hemodilution During Incremental Fluid Administration
- Masimo (NASDAQ:MASI) announced today the findings of an abstract presented at Euroanaesthesia 2018 in which re...
-
June 04, 2018 14:00 KST
- Results of Phase III RELEVANCE Study Comparing REVLIMID plus Rituximab (R2) Versus Rituximab Plus Chemotherapy in Patients with Previously Untreated Follicular Lymphoma to be Presented at ASCO 2018
- Celgene Corporation (NASDAQ:CELG) today announced additional results from RELEVANCE, a phase III, randomized, ...
-
June 04, 2018 13:40 KST
- BRIC INVEST Offers Aimedis - AIM ICO: Leveraging Blockchain and AI for a Sound eHealth Investment
- Dutch eHealth-provider Aimedis, creator of a blockchain and AI-based platform that allows patients and institu...
-
June 04, 2018 11:50 KST
- Results of Phase III OPTIMISMM Study Presented at ASCO 2018 Showed the PVd Triplet Improved PFS in Early Lines of Relapsed or Refractory Multiple Myeloma
- Celgene Corporation (NASDAQ:CELG) today announced results from the OPTIMISMM study, a phase III, randomized, o...
-
May 30, 2018 11:45 KST
- ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies
- ResMed (NYSE:RMD, ASX:RMD), a global leader in connected healthcare solutions, today announced it has entered ...
-
May 30, 2018 09:50 KST
- Large-Scale Study Provides First-Ever Insights into the Genetic Causes of Bedwetting
- New evidence from the world’s first genome-wide association study (GWAS) identifies genes and genetic variants...
-
May 29, 2018 11:30 KST
- Octapharma Share Promising Preclinical Data for SubQ-8, a Novel Subcutaneous Recombinant FVIII, at WFH 2018
- Octapharma announced today that pre-clinical data for SubQ-8 were presented during a symposium at the recent W...
-
May 29, 2018 11:20 KST
- Octapharma present new data on the benefits of Nuwiq® in patients with haemophilia A at the World Federation of Hemophilia 2018 World Congress
- Octapharma announced today that new data on the benefits of Nuwiq® in patients with haemophilia A were present...
-
May 25, 2018 19:10 KST
- Public Health Leaders Urge FDA to Issue Final Rule for Reducing Nicotine in Cigarettes by March 2019
- 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm redu...
-
May 25, 2018 11:30 KST
- ResMed Studies Show Remote Monitoring and Automated Resupply Improve Adherence to PAP Therapy
- Remote patient monitoring and resupply programs have been shown to improve patient adherence to positive airwa...
-
May 25, 2018 10:25 KST
- Geltor Inc. Wins Prestigious 2018 CEW Innovation Award
- Geltor, Inc., the ingredient design company, was named the winner of the 2018 CEW Beauty “Innovation of the Ye...
-
May 24, 2018 11:45 KST
- Spiolto® Respimat® enables greater physical activity in people living with Chronic Obstructive Pulmonary Disease
- For media excluding US/Canada and UK
Boehringer Ingelheim announced data which add to the growing body of e...
-
May 23, 2018 20:35 KST
- Efficacy and safety of OFEV® reinforced in new presentations at ATS 2018
- Boehringer Ingelheim today announced new presentations at the American Thoracic Society’s 2018 annual conferen...
-
May 23, 2018 19:50 KST
- Nearly 1 Billion People Worldwide Have Sleep Apnea, International Sleep Experts Estimate
- A new data analysis presented by ResMed (NYSE: RMD, ASX: RMD) this week at the ATS 2018 International Conferen...
-
May 23, 2018 19:20 KST
- Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1
- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission has gra...
-
May 23, 2018 19:10 KST
- ResMed-sponsored Studies Show Combining Home Oxygen and Home Non-invasive Ventilation is a Cost Effective Treatment for COPD
- ResMed (NYSE: RMD, ASX: RMD) announced today the results of two clinical analyses conducted for the U.K. and U...
-
May 23, 2018 19:05 KST
- Takeda to Highlight Broad Oncology Portfolio and Pipeline Data at the American Society of Clinical Oncology (ASCO) and the Congress of the European Hematology Association (EHA) Annual Meetings
- Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the company will feature a total of 14 ...
-
May 16, 2018 14:25 KST
- Cerveau Technologies, Inc. Signs Research Agreement with Tokyo Metropolitan Institute of Gerontology, Japan
- Cerveau Technologies Inc. today announced an agreement with the Tokyo Metropolitan Institute of Gerontology in...
-
May 15, 2018 15:30 KST
- Takeda Reports FY2017 Full Year Results and Issues FY2018 Guidance
- Takeda Pharmaceutical Company Limited (TOKYO:4502):
Underlying Revenue growth +5.5% led by Takeda's Gr...
-
May 15, 2018 13:20 KST
- Anatara Announces Exclusive Global License Agreement with Zoetis
- Anatara Lifesciences (ASX:ANR) is delighted to announce an exclusive licensing agreement with Zoetis Inc., the...
-
May 15, 2018 11:10 KST
- New Study Investigates the Economic Impact and Utility of Continuous Noninvasive Hemoglobin Measurement with Masimo SpHb® in Reducing Unnecessary Blood Transfusions
- Masimo (NASDAQ: MASI) announced today the findings of a recently published study in which researchers evaluate...
-
May 11, 2018 13:30 KST
- ResMed’s New QuietAir Diffuser Vent for CPAP Masks Reduces Noise by 89 Percent
- ResMed (NYSE: RMD) (ASX: RMD) today introduced the QuietAir diffuser vent elbow, for its latest continuous pos...
-
May 10, 2018 14:20 KST
- The Australian and New Zealand College of Anaesthetists Joins the Patient Safety Movement Foundation as a Committed Partner to Eliminate Preventable Harm in Hospitals
- The Australian and New Zealand College of Anaesthetists (ANZCA) is partnering with the Patient Safety Movement...
-
May 09, 2018 14:15 KST
- Proposed Acquisition of Shire plc by Takeda
- Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and Shire plc (LON: SHP) (“Shire”) today announce...
-
May 04, 2018 10:15 KST
- Ferring Signs Global Agreement to Commercialise Novel Gene Therapy for Bladder Cancer Patients
- Ferring Pharmaceuticals today announced the signing of an agreement giving the company the option to secure gl...
-
May 03, 2018 13:55 KST
- Boston Healthcare Adds Seasoned Market Access Leader to Global Life Science Consulting Team
- Boston Healthcare Associates Inc. (Boston Healthcare), a global life sciences consulting firm, today announced...
-
May 03, 2018 09:55 KST
- ZOLL Awarded Singapore’s Save-A-Life Initiative to Install 5,000 AED Plus Units in Public Housing
- ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software...
-
April 26, 2018 11:45 KST
- Boehringer Ingelheim R&D Pushes to Transcend Disease Boundaries
- Family-owned pharmaceutical company Boehringer Ingelheim today presented its latest pipeline updates at a Rese...
-
April 25, 2018 16:15 KST
- Sixteen Healthcare Groups Make Major Commitments at 2nd Annual Patient Safety Rally in Taiwan
- The Patient Safety Movement Foundation (PSMF) joined the Taiwan Patient Safety Culture Club (TPSCC) at the 2nd...
-
April 25, 2018 11:20 KST
- New Analyses from Pivotal Phase III Trials of Oral Ozanimod in Relapsing Multiple Sclerosis To Be Presented at the 2018 American Academy of Neurology Annual Meeting
- Celgene Corporation (NASDAQ:CELG) today announced additional phase III data analyses evaluating the efficacy a...
-
April 24, 2018 19:40 KST
- HitGen Announces Research Collaboration and License Agreement with Simcere
- Simcere Pharmaceutical Group (Simcere) and HitGen Ltd (HitGen) announced today that they have entered into a l...
-
April 20, 2018 17:35 KST
- New Study Investigates the Utility of Masimo SpHb® in Post-operative Red Blood Cell (RBC) Transfusion Best Practices
- Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at the 2018 Annual Meeting of the ...
-
April 18, 2018 09:00 KST
- Twist Bioscience Accelerates Global Expansion with Strategic Asia Pacific Distribution Agreements
- Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality syn...
-
April 17, 2018 13:45 KST
- The Health Industry Summit (tHIS) to Play a Greater Role as China Set to Boost Health Industry for a Higher Level of National Health Care
- The Health Industry Summit (tHIS) 2018 hosted by Reed Sinopharm, opened in Shanghai at the National Exhibition...
-
April 17, 2018 11:15 KST
- Boehringer Ingelheim and Lilly Announce an Academic Collaboration with University of Oxford to Investigate the Effects of Empagliflozin in People with Chronic Kidney Disease
- Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced an academic collaboration with the U...
-
April 16, 2018 12:00 KST
- Patient Safety Movement Foundation Supports the Tokyo Declaration on Patient Safety
- The Patient Safety Movement Foundation (PSMF) announced its support for the Tokyo Declaration on Patient Safet...
-
April 12, 2018 09:45 KST
- Boehringer Ingelheim to invest €65 million in avian vaccines
- Six months after inaugurating its new French animal health headquarters in the heart of the Lyon-Gerland Biodi...
-
April 11, 2018 18:10 KST
- HeartSciences Announces Publication of Clinical Study Results in the Journal of the American College of Cardiology (JACC)
- HeartSciences, a medical device company leading innovation in electrocardiography through the application of c...
-
April 11, 2018 12:00 KST
- JPT Peptide Technologies Launches The Human Proteome Peptide Catalog
- JPT Peptide Technologies (JPT) announces the launch of The Human Proteome Peptide Catalog, the first and most ...
-
April 10, 2018 19:20 KST
- Swiss Advanced Vision Launches Active Intraocular Lens Concept with Real-Time Autofocus for Cataract Surgery
- Swiss Advanced Vision (SAV-IOL) has announced the launch of Project R-TASC, set to disrupt the global intraocu...
-
April 10, 2018 16:55 KST
- HeartSciences Showcases MyoVista® Wavelet ECG at 2018 China International Medicinal Equipment Fair (CMEF)
- HeartSciences, an innovative medical device company, is proud to announce its participation as an exhibitor at...
-
April 06, 2018 09:40 KST
- Ferring Acquires Innovative Biotechnology Company and Microbiome Pioneer Rebiotix Inc.
- Ferring Pharmaceuticals* and Rebiotix Inc. today announce that they have agreed to the acquisition of Rebiotix...
-
April 05, 2018 13:15 KST
- Boehringer Ingelheim and OSE Immunotherapeutics Announce Global Immuno-Oncology Partnership to Develop a Pioneering Checkpoint Inhibitor for the Treatment of Advanced Solid Tumors
- Boehringer Ingelheim and OSE Immunotherapeutics, a biotechnology company focused on the development of innovat...
-
April 04, 2018 14:25 KST
- Impossible Foods Announces $114 Million Convertible Note as Startup Prepares for Rapid Expansion in the US and Overseas
- Impossible Foods announced today the successful closing of about $114 million in convertible note financing.
...
-
April 03, 2018 13:10 KST
- ResMed Hires Bobby Ghoshal as First Chief Technology Officer
- ResMed (NYSE: RMD, ASX: RMD) today announced the hire of its first chief technology officer (CTO), Bobby Ghosh...
-
April 02, 2018 15:00 KST
- PharmAbcine Announces FDA Orphan Drug Designation Granted to TTAC-0001 for Glioblastoma Multiforme
- PharmAbcine Inc., a clinical-stage biotech company developing novel antibody therapeutics for multiple cancer ...
-
March 30, 2018 14:25 KST
- Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine[1]
- Boehringer Ingelheim today announced data from the landmark 52-week DYNAGITO® trial which show that in people ...
